West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at ...

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...

West Pharmaceutical Services, Inc. (NYSE:WST) reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72 ...

New Mexico Educational Retirement Board decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results , with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue ...